BioLattice

EyeYon

This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.

StemSight

This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.

Neuro Modulation Artificial Retina

This company develops a high-acuity spherical bionic retinal implant to restore vision for patients with retinitis pigmentosa or age-related macular degeneration.

LambdaVision

This company develops protein-based artificial retinas in microgravity to restore vision for patients with retinitis pigmentosa and age-related macular degeneration.

RhyGaze

This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.

Phosphoenix

The company develops an implantable neuroprosthetic system to restore functional vision in people with profound blindness by directly stimulating the brain's visual pathway.

Cornea Project

This company develops point-of-care diagnostic devices and molecular biomarker analysis technologies for ophthalmologists to detect corneal diseases like keratoconus and dry eye syndrome.

Bioaesthetics

This company develops biologically derived collagen grafts to regenerate nipples and areolas for patients undergoing breast reconstruction surgery after mastectomies.